Patients and Science are at the Center of Everything we do at Sanoﬁ
This is reflected in our relationships and work with U.S. patient advocacy groups. Sanofi recognizes and respects the vital and tireless work that patient advocacy groups perform every day on behalf of the patients and families they serve. We engage with the patient advocacy community to listen to their perspectives, understand what matters most to patients, and champion these patient-centric insights internally and externally.
Partnering on Shared Goals Focused on the Needs of Patients
We engage with patient advocacy groups from early research throughout the lifecycle of Sanofi medicines and vaccines. Partnerships work to achieve shared goals with the U.S. patient advocacy community that are focused on patients:
Engage patients to accelerate research and development of breakthrough medicines and vaccines
Improve appropriate patient access and affordability
Empower patients to have informed discussions with their providers and improve their health
Principles That Deﬁne Our Approach with Patient Advocacy Groups
How we partner is driven by:
- Truly listening
- Open, honest dialogue
- Mutual respect
- Collaboration and partnerships
- Highest standard of ethics and integrity
At a Glance: Working with the Advocacy Community
Sanoﬁ 2022 Patient Advocacy Council: Patient Access to Transformative Medicines and Vaccines
The Sanoﬁ U.S. Public Aﬀairs & Patient Advocacy Team aspires to be the partner of the U.S. patient advocacy community that improves patient access to medicines and vaccines that can potentially transform lives and change the practice of medicine. We want to be a partner who listens, acts and leads.
Eric Racine, Vice President & Head, US Public Aﬀairs & Patient Advocacy
Sponsorships and Contributions
Sanofi supports specific activities and initiatives of U.S. patient advocacy groups that are focused on improving patient care. Sponsorship requests are submitted through applications completed on our online portals to be evaluated by an internal committee.
Patient-Centered Healthcare Value Assessment
We have a commitment to promoting healthcare systems that make our treatments accessible and affordable to patients in need. We encourage a transition to value-driven healthcare—when access is aligned with the highest-quality care—while enabling us to continue to advance scientific knowledge and bring innovative treatments to patients worldwide.
Health Equity at Sanofi in the U.S.
We believe every person should have the opportunity to be as healthy as possible, and no one should be disadvantaged from getting the care they deserve.
Our goal is to accelerate health equity so all patients have access to transformative medicines and vaccines.
We are proud of our relationships and interactions with patient advocacy groups, which are conducted according to the highest standards of integrity, with professionalism, and full respect for independence. Sanofi voluntarily discloses our annual payments to patient advocacy groups (PAGs).
Patient Access and Aﬀordability
Sanofi has multiple programs and resources to support patients with access and affordability for their medications and to provide assistance to those with specific needs.